Dr. Rinat Bernstein Molho Kansarka naasaha
Khabiir sare oo ka tirsan Unugga Kansarka Naasaha, Machadka Oncology, Khibrad:
Booqashada BuuggaKu saabsan Dhakhtarka
Dr. Rinat Bernstein-Molho waxay ka qalin jabisay machadka Israel ee teknolojiyadda caafimaadka ee Haifa sanadkii 2004. Waxay dhameystirtay degenaanshaha Medical Oncology ka dibna degenaansho dheeri ah oo ku saabsan Caafimaadka Genetics ee Xarunta Caafimaadka ee Tel Aviv. Waxay mas'uul ka ahayd bukaan socod eegtada kansarka ee Xarunta Caafimaadka Tel Aviv.
Way ku biirtay Kansarka naasaha institute in the Sheba Medical Center at Tel Hashomer in 2017, where she works as a medical oncologist and clinical cancer geneticist. Her area of clinical and research interest is hereditary cancers.
Waxbarashada iyo Tababarka
- Dr. Rinat Bernstein Molho wuxuu si sharaf leh uga qalin jabiyay Kulliyadda Caafimaadka ee Jaamacadda Technion, Haifa.
- Kadib waxay ku takhasustay cilmiga Oncology ee Waaxda Oncology, Xarunta Caafimaadka Tel Aviv.
- Sidoo kale waxay ku takhasustay cilmiga Genetics ee Machadka Genetics, Tel Aviv Medical Center.
Daraasado & Qorfeyn
Saxnimada Qaababka Saadaalinta Khatarta ee Kansarka Naasaha iyo BRCA1 / BRCA2 Isbedelayaasha Xambaara Is-beddelka Isreal. Kenan ES, Friger M, Shochat-Bigon D, Schayek H, Bernstein-Molho R, Friedman E.
Soo saarista BRCA1 / 2 genotyping ee Israel ee halista sare leh ee bukaanka kansarka naasaha / ugxansidaha oo aan wadan isbeddellada ugu badan. Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, Kalis ML, Peretz T, Shohat M, Basel-Salmon L, Friedman E, Bazak L, Goldberg Y.
Qiimeynta dulqaadka iyo waxtarka ee lagu daro karboplatin-ka ku jira neoadjuvant anthracycline iyo daaweynta ku saleysan taxane ee BRCA1 ayaa lagu xoojiyay koox ka kooban kansarka naasaha oo seddex-xumaan ah. Sella T, Gal Yam EN, Levanon K, Rotenberg TS, Gadot M, Kuchuk I, Molho RB, Itai A, Modiano TM, Gold R, Kaufman B, Shimon SP.
Hospital
takhasus
Nidaamyada la fuliyay
Kansarka naasaha